| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/15/2005 | EP1539141A1 -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| 06/15/2005 | EP1450808B1 Quinazoline derivatives for the treatment of t cell mediated diseases |
| 06/15/2005 | EP1448560B1 3-SUBSTITUTED OXINDOLE beta 3 AGONISTS |
| 06/15/2005 | EP1368337B1 Piperazine derivatives and their use as 5-ht1b ligands |
| 06/15/2005 | EP1349856B1 Isoindolin-1-one glucokinase activators |
| 06/15/2005 | EP1345609B1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 06/15/2005 | EP1278740B1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
| 06/15/2005 | EP1126843A4 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 06/15/2005 | EP0975602B1 Imidazole and imidazoline derivatives and uses thereof |
| 06/15/2005 | CN1628113A Substituted indoles as alpha-1 agonists |
| 06/15/2005 | CN1628104A Quinazolinone derivatives and their use as CB agonists |
| 06/15/2005 | CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 06/15/2005 | CN1626532A Amide compounds |
| 06/15/2005 | CN1626513A Organometallic complexes and organic electroluminescence device using the same |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1205932C Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury |
| 06/14/2005 | US6906103 Compounds possessing antibacterial, antifungal or antitumor activity |
| 06/14/2005 | US6906095 Central nervous system disorders; anxiolytic agents; antidepressants; muscular disorders |
| 06/14/2005 | US6906093 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 06/14/2005 | US6906084 Indole derivatives as factor Xa inhibitors |
| 06/14/2005 | US6906078 Method of using (H+/K+) ATPase inhibitors as antiviral agents |
| 06/14/2005 | US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH |
| 06/14/2005 | US6906074 A tachykinin antagonist for used as antiinflammatory agent, antiallergic agent, analgesic, antiemetics, treating irritable colon syndrome, skin disorders |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | US6906070 Anticoagulants |
| 06/14/2005 | US6906067 Block cytokine production via inhibition of p38 kinase; triamino-s-triazine compounds; treating rheumatoid arthritis |
| 06/14/2005 | US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/14/2005 | US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 06/14/2005 | US6906056 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906006 Applying to plants, environment |
| 06/14/2005 | CA2155323C Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof |
| 06/09/2005 | WO2005051951A1 A2b adenosine receptor antagonists |
| 06/09/2005 | WO2005051943A1 Processes for the preparation of highly pure irbesartan |
| 06/09/2005 | WO2005051942A1 Indazole compounds and methods of use thereof as protein kinase inhibitors |
| 06/09/2005 | WO2005051929A1 Conversion of aromatic nitriles into tetrazoles |
| 06/09/2005 | WO2005051928A1 Process for production of tetrazolyl compounds |
| 06/09/2005 | WO2005051923A1 Quinazoline derivatives |
| 06/09/2005 | WO2005051918A1 Cationic diaminopyrazoles, a method for the production thereof and dyes containing these compounds |
| 06/09/2005 | WO2005051917A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 06/09/2005 | WO2005051908A1 Indole derivatives for use as chemical uncoupler |
| 06/09/2005 | WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051391A1 Quinazolinone compounds with reduced bioaccumulation |
| 06/09/2005 | WO2005051381A1 Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R) |
| 06/09/2005 | WO2005051380A1 Substituted urea-octahydroindols as antagonists of melanin concentrating hormone receptor 1 (mch1r) |
| 06/09/2005 | WO2005051366A2 Diaryl urea derivatives in the treatment of protein kinase dependent diseases |
| 06/09/2005 | WO2005051308A2 Methods of treating diseases and disorders by targeting multiple kinases |
| 06/09/2005 | WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | WO2005042518A3 Substituted heterocyclic compounds and methods of use |
| 06/09/2005 | WO2005035508A3 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/09/2005 | WO2005021535A3 A method of removing the triphenylmethane protecting group |
| 06/09/2005 | WO2005016893A3 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 06/09/2005 | WO2003088897A3 Fab i inhibitors |
| 06/09/2005 | US20050124683 Viricides; immunomoderators |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124662 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 06/09/2005 | US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma |
| 06/09/2005 | US20050124640 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/09/2005 | US20050124620 Indole derivatives having an acidic moiety that inhibit or modulate activity of p38 map kinase mediating a disease state; e.g., 3-(2-(4-pyridyl)ethyl)-5-(3-trifluoromethoxybenzamido)indole; enzyme inhibitors; antiarthritic, -inflammatory, and -carcinogenic agents; respiratory disorders; AIDS; Alzheimer's |
| 06/09/2005 | US20050124619 Medical devices employing triazine compounds and compositions thereof |
| 06/09/2005 | US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124603 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 06/09/2005 | US20050124602 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; treating a thromboembolic disorder such as deep vein thrombosis or pulmonary embolism |
| 06/09/2005 | US20050124600 And thiones, 1-substituted with a (hetero)aryl)carbonyl group, e.g., 6-Bromo-1-[[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]-8-methyl-3-(1-methylethyl)-2,4(1H,3R)-quinazolinedione; especially for use in growing and stored agronomic crops |
| 06/09/2005 | US20050124562 Using Dna polymerase inhibitor as bactericide |
| 06/09/2005 | CA2546754A1 Akt protein kinase inhibitors |
| 06/09/2005 | CA2546733A1 A2b adenosine receptor antagonists |
| 06/09/2005 | CA2546673A1 Diaryl urea derivatives in the treatment of protein kinase dependent diseases |
| 06/09/2005 | CA2546493A1 Indazole compounds and methods of use thereof as protein kinase inhibitors |
| 06/09/2005 | CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2546360A1 Methods of treating diseases and disorders by targeting multiple kinases |
| 06/09/2005 | CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/09/2005 | CA2545659A1 Bicyclic inhibitors of mek |
| 06/09/2005 | CA2545601A1 Quinazolinone compounds with reduced bioaccumulation |
| 06/09/2005 | CA2545262A1 Quinazoline derivatives |
| 06/09/2005 | CA2544519A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1537879A1 Preventive and/or therapeutic drugs for asthma |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537111A1 Hetereoaryl nitrile derivatives |
| 06/08/2005 | EP1537101A1 Tetrahydropyridazine derivatives having a pesticidal effect |
| 06/08/2005 | EP1537098A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1537089A2 Compounds compositions and methods |
| 06/08/2005 | EP1537087A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 06/08/2005 | EP1537078A1 Indoles having anti-diabetic activity |
| 06/08/2005 | EP1536799A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties |
| 06/08/2005 | EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1019045B1 Antithrombotic agents |
| 06/08/2005 | CN1625555A Quinazoline compounds |
| 06/08/2005 | CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/08/2005 | CN1625551A Manufacturing method of 6-aminomethyl-6, 11-dihydro-5H-dibenzo.[b, e] azepine |
| 06/08/2005 | CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative |
| 06/08/2005 | CN1625400A 2, 4-pyrimidinediamine compounds and their uses |
| 06/08/2005 | CN1623992A Novel medicine of non peptide like angiotensin II receptor antagonism agent, their preparation and application |